Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 35,141 | 10,283 | 3,559 | 52,480 | 42,141 |
| Gross Profit | 35,141 | 10,283 | 3,559 | 52,480 | 42,141 |
| Operating Expenses | 155,956 | 115,627 | 111,045 | 113,896 | 108,639 |
| Operating Income | -120,815 | -105,344 | -107,486 | -61,416 | -66,498 |
| Other Income | 11,034 | 6,660 | 4,187 | 2,649 | 1,278 |
| Pre-tax Income | -109,781 | -98,684 | -103,299 | -58,767 | -65,220 |
| Income Tax | N/A | -6 | N/A | 27 | N/A |
| Net Income Continuous | -109,781 | -98,678 | -103,299 | -58,794 | -65,220 |
| Net Income | $-109,781 | $-98,678 | $-103,299 | $-58,794 | $-65,220 |
| EPS Basic Total Ops | -0.80 | -0.75 | -0.84 | -0.48 | -0.53 |
| EPS Basic Continuous Ops | -0.80 | -0.75 | -0.84 | -0.48 | -0.53 |
| EPS Diluted Total Ops | -0.80 | -0.75 | -0.84 | -0.48 | -0.53 |
| EPS Diluted Continuous Ops | -0.80 | -0.75 | -0.84 | -0.48 | -0.53 |
| EBITDA(a) | $-118,621 | $-104,320 | $-106,033 | $-58,853 | $-62,792 |